SCHEMBL14747601

SCHEMBL14747601

Nc1ccc(-n2ncc(F)c2-c2ccccc2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.68
PTGS1 P23219 4/20 0.68
RAB9A P51151 4/20 0.46
NPC1 O15118 3/20 0.46
S1PR1 P21453 2/20 0.43
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
HSP90AA1 P07900 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
NR3C1 P04150 1/20 0.41
MAPK14 Q16539 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
GFER P55789 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14747808 0.88 PTGS2 (0.68) PTGS2PTGS1RAB9ANPC1S1PR1
SCHEMBL6338986 0.81 PTGS2 (1.00) PTGS2PTGS1
SCHEMBL15779176 0.81 PTGS2 (0.65) PTGS2PTGS1RAB9ANPC1S1PR1
SCHEMBL27333012 0.78 PTGS2 (0.69) PTGS2PTGS1RAB9ANPC1LMNA
SCHEMBL31276318 0.71 PTGS2 (0.52) PTGS2PTGS1RAB9ANPC1S1PR1
SCHEMBL14747602 0.70 PTGS2 (0.70) PTGS2PTGS1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL31306253 0.69 KEAP1 (0.39) PTGS2PTGS1RAB9ANPC1LMNA
SCHEMBL3446332 0.69 CA1 (0.46) PTGS2PTGS1RAB9ANPC1SMN1; SMN2
SCHEMBL20603979 0.69 CYP11B1 (0.52) PTGS2PTGS1RAB9ANPC1LMNA
SCHEMBL8688579 0.69 PTGS2 (0.64) PTGS2PTGS1LMNANPSR1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE44048-E1 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonamide for the treatment of inflammation or an inflammation-associated disorder G.D. SEARLE LLC (US) 2013-03-05 US disclosed